Sibutramine is no longer marketed in the United States. Because there is no published experience with sibutramine during breastfeeding, an alternate therapy may be preferred, especially while nursing a newborn or preterm infant. Information on the effect of sibutramine on serum prolactin is somewhat conflicting.
西布曲明在美国已不再上市。由于尚无关于西布曲明在母乳喂养期间的公开经验，因此可能更倾向于选择替代疗法，尤其是在哺育新生儿或早产儿期间。关于西布曲明对血清催乳素影响的信息存在一定冲突。
